[
    {
        "content": "* Q1 earnings per share view $0.17 -- Thomson Reuters I/B/E/S",
        "date": "11062017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent Q1 earnings per share $0.03 "
    },
    {
        "content": "* Catalent completes repricing and extension of credit agreement Source text for Eikon: Further company coverage:",
        "date": "10182017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent completes repricing and extension of credit agreement "
    },
    {
        "content": "* Catalent announces pricing of private offering of senior unsecured notes due 2026",
        "date": "10162017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent announces pricing of private offering of senior unsecured notes due 2026 "
    },
    {
        "content": "* Catalent announces launch of private offering of $450 million of senior unsecured notes due 2026",
        "date": "10102017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent launches private offering of $450 mln of senior unsecured notes due 2026 "
    },
    {
        "content": "* Catalent Inc announces pricing of public offering of common stock to fund part of its acquisition of Cook Pharmica",
        "date": "09272017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent Inc announces pricing of public offering "
    },
    {
        "content": "* Catalent Inc announces public offering of common stock to fund part of its acquisition of Cook Pharmica",
        "date": "09252017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent announces public offering of common stock to fund part of its acquisition of Cook Pharmica "
    },
    {
        "content": "U.S. drug contract manufacturer Catalent Inc  agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.",
        "date": "09192017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "Catalent bolsters biopharma business with Cook Pharmica buy "
    },
    {
        "content": "* Catalent Inc - files for common stock offering of upto $\u200d\u200b250.0 million- SEC Filing Source text:(http://bit.ly/2xGCzV4) Further company coverage:",
        "date": "09252017",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent files for common stock offering of upto $\u200d\u200b250 million "
    },
    {
        "content": "Sept 19 U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.",
        "date": "09192017",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "UPDATE 2-Catalent bolsters biopharma business with Cook Pharmica buy "
    },
    {
        "content": "Sept 19 U.S. drug delivery technology company Catalent Inc said on Tuesday it would buy privately held Cook Pharmica LLC for $950 million in cash.",
        "date": "09192017",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "Catalent to buy Cook Pharmica for $950 mln "
    },
    {
        "content": "* $750 million of deal value to be paid at closing and balance to be paid in equal installments\u200b",
        "date": "09192017",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent Inc to acquire Cook Pharmica for $950 million "
    },
    {
        "content": "* Catalent  Inc. Reports fourth quarter and full year 2017 results",
        "date": "08282017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent Q4 adjusted non-GAAP earnings per share $0.65 "
    },
    {
        "content": "* Catalent  Inc. reports third quarter fiscal year 2017 results",
        "date": "05042017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent reports Q3 earnings per share $0.21 "
    },
    {
        "content": "* Catalent Inc reports second quarter fiscal year 2017 results",
        "date": "02062017",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent reports Q2 earnings per share $0.14 "
    },
    {
        "content": "* Catalent announces launch of private offering of $400 million (U.S. Dollar equivalent) of Euro-denominated senior unsecured notes due 2024",
        "date": "11282016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent launches private offering of $400 mln of Euro-denominated senior unsecured notes due 2024 "
    },
    {
        "content": "* Catalent acquires Accucaps to expand softgel development and manufacturing capabilities and capacity",
        "date": "11282016",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent acquires Accucaps to expand softgel development and manufacturing capabilities and capacity "
    },
    {
        "content": "* There is no change to Catalent's previously issued financial guidance for fiscal year 2017",
        "date": "11072016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent reports Q1 fiscal year 2017 results "
    },
    {
        "content": "* Catalent Inc - board decreased its size from 10 directors to 9",
        "date": "10312016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent appoints Uwe R\u00f6hrhoff to its board of directors "
    },
    {
        "content": "* Says secondary offering of about 19.0 million shares of Catalent's common stock  Source text for Eikon:  Further company coverage:",
        "date": "09062016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent announces secondary offering of about 19 mln shares of co's common stock "
    },
    {
        "content": "* Q4 revenue $532.2 million versus I/B/E/S view $502.2 million",
        "date": "08292016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent Q4 earnings per share $0.46 "
    },
    {
        "content": "* Files for potential stock shelf  size undisclosed - SEC filing  Source text - http://1.usa.gov/1raqzUx Further company coverage:",
        "date": "06062016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent files for potential stock shelf  size undisclosed "
    },
    {
        "content": "* Catalent  Inc. announces secondary public offering of common stock",
        "date": "06062016",
        "name": "Catalent Inc",
        "news_type": "normal",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent announces secondary public offering of common stock "
    },
    {
        "content": "* Catalent Inc announces closing of secondary public offering of common stock  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1 646 223 8780)",
        "date": "06092016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent announces closing of secondary public offering "
    },
    {
        "content": "* Q3 earnings per share view $0.31 -- Thomson Reuters I/B/E/S",
        "date": "05042016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "BRIEF-Catalent reports Q3 earnings per share $0.08 "
    },
    {
        "content": "NEW YORK/FRANKFURT Swiss specialty chemicals and life sciences company Lonza Group AG  has offered to acquire U.S. drug delivery technology company Catalent Inc   three people familiar with the matter said this week.",
        "date": "04132016",
        "name": "Catalent Inc",
        "news_type": "topStory",
        "symbol": "CTLT",
        "title": "Exclusive: Lonza in bid to acquire Catalent - sources "
    }
]